Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients
- 31 August 2006
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 5 (7), 493-498
- https://doi.org/10.1016/j.autrev.2006.01.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cyclosporine Suppresses Cell Growth and Collagen Production in Hepatic Stellate CellsTransplantation Proceedings, 2005
- Immunosuppression for HCV Following Liver Transplantation: Enough Is Just EnoughTransplantation, 2004
- RESULTS OF LIS2T, A MULTICENTER, RANDOMIZED STUDY COMPARING CYCLOSPORINE MICROEMULSION WITH C2 MONITORING AND TACROLIMUS WITH C0 MONITORING IN DE NOVO LIVER TRANSPLANTATIONTransplantation, 2004
- Impact of cyclosporine on the development of immunosuppressive therapy in liver transplantationTransplantation Proceedings, 2004
- Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejectionLiver Transplantation, 2003
- A model to predict severe HCV-related disease following liver transplantationHepatology, 2003
- Hepatitis C and liver transplantationJournal of Hepatology, 2001
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- Quantitation of hepatitis C virus RNA in liver transplant recipientsGastroenterology, 1994
- Recurrent and acquired hepatitis C viral infection in liver transplant recipientsGastroenterology, 1992